Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:58 pm Purchase |
2021-12-31 | 13G | 2seventy bio, Inc. TSVT |
EcoR1 Capital LLC | 1,917,063 8.200% |
26,400 (+1.40%) |
Filing History |
| 2022-02-14 3:22 pm Sale |
2021-12-31 | 13G | Shattuck Labs, Inc. STTK |
EcoR1 Capital LLC | 0 0.000% |
-3,295,088 (Position Closed) |
Filing History |
| 2022-02-14 3:21 pm Purchase |
2021-12-31 | 13G | Alector, Inc. ALEC |
EcoR1 Capital LLC | 4,994,970 6.100% |
252,336 (+5.32%) |
Filing History |
| 2022-02-14 3:21 pm Purchase |
2021-12-31 | 13G | Ovid Therapeutics Inc. OVID |
EcoR1 Capital LLC | 6,082,200 8.900% |
6,082,200 (New Position) |
Filing History |
| 2022-02-14 3:19 pm Purchase |
2021-12-31 | 13G | Solid Biosciences Inc. SLDB |
EcoR1 Capital LLC | 613,513 8.300% |
81,667 (+15.36%) |
Filing History |
| 2022-02-14 3:03 pm Purchase |
2021-12-31 | 13G | Avidity Biosciences, Inc. RNA |
EcoR1 Capital LLC | 2,759,505 5.900% |
655,555 (+31.16%) |
Filing History |
| 2022-02-14 3:03 pm Sale |
2021-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX |
EcoR1 Capital LLC | 43,031 2.000% |
-113,104 (-72.44%) |
Filing History |
| 2022-02-14 3:02 pm Purchase |
2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital LLC | 3,468,944 8.800% |
376,726 (+12.18%) |
Filing History |
| 2022-02-14 3:01 pm Purchase |
2021-12-31 | 13G | Morphic Holding, Inc. MORF |
EcoR1 Capital LLC | 3,951,566 10.700% |
1,111,682 (+39.15%) |
Filing History |
| 2022-02-14 2:38 pm Unchanged |
2021-12-31 | 13G | Atreca, Inc. BCEL |
EcoR1 Capital LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-14 2:17 pm Sale |
2021-12-31 | 13G | Geron Corporation GERN |
EcoR1 Capital LLC | 9,615,385 2.900% |
-18,939,925 (-66.33%) |
Filing History |
| 2022-02-14 2:16 pm Sale |
2021-12-31 | 13G | Atreca, Inc. BCEL |
EcoR1 Capital LLC | 0 0.000% |
-2,426,685 (Position Closed) |
Filing History |
| 2022-02-14 2:15 pm Unchanged |
2020-12-31 | 13G | Savara Inc. SVRA |
EcoR1 Capital LLC | 3,040,540 5.300% |
0 (Unchanged) |
Filing History |
| 2022-02-14 2:15 pm Sale |
2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
EcoR1 Capital LLC | 253,897 1.700% |
-111,111 (-30.44%) |
Filing History |
| 2022-02-14 1:39 pm Purchase |
2021-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
EcoR1 Capital LLC | 6,319,232 9.300% |
1,384,300 (+28.05%) |
Filing History |
| 2022-02-14 1:38 pm Sale |
2021-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY |
EcoR1 Capital LLC | 1,060,010 3.000% |
-1,473,625 (-58.16%) |
Filing History |
| 2022-02-14 1:38 pm Sale |
2021-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
EcoR1 Capital LLC | 0 0.000% |
-4,368,500 (Position Closed) |
Filing History |
| 2022-02-14 1:37 pm Sale |
2021-12-31 | 13G | AC Immune SA ACIU |
EcoR1 Capital LLC | 749,585 0.900% |
-3,952,575 (-84.06%) |
Filing History |
| 2022-02-14 12:49 pm Purchase |
2021-12-31 | 13G | Xencor, Inc. XNCR |
EcoR1 Capital LLC | 4,906,106 8.400% |
359,034 (+7.90%) |
Filing History |
| 2022-02-02 7:52 pm Purchase |
2022-01-27 | 13G | Galapagos NV GLPG |
EcoR1 Capital LLC | 3,407,246 5.200% |
3,407,246 (New Position) |
Filing History |